Understanding the Diagnosis: Classic CAH, Simple Virilizing Form
At a Glance
Simple virilizing congenital adrenal hyperplasia (SV-CAH) is a genetic condition where the adrenal glands lack enough enzyme to make cortisol, leading to excess male hormones. With daily hormone replacement medication and strict sick day rules, people with SV-CAH can live healthy, active lives.
Receiving a diagnosis of Congenital Adrenal Hyperplasia (CAH) can feel overwhelming, but understanding the specific “simple virilizing” form can help you manage the condition effectively. CAH is a genetic disorder that affects the adrenal glands, which sit on top of the kidneys and produce essential hormones [1][2].
In the Simple Virilizing (SV) form, the body has a partial deficiency of an enzyme called 21-hydroxylase. This enzyme is needed to make cortisol (the “stress hormone”) and aldosterone (the hormone that balances salt and water) [1][3].
The CAH Spectrum
CAH is often described as a spectrum based on how much enzyme activity remains.
| Feature | Salt-Wasting (SW) | Simple Virilizing (SV) | Non-Classic (NC) |
|---|---|---|---|
| Enzyme Activity | 0-1% [4] | 1-2% [4] | 20-60% [4] |
| Cortisol Production | Deficient | Deficient | Normal or slightly low |
| Aldosterone Production | Deficient (life-threatening without meds) | Sufficient to prevent daily crises | Normal |
| Typical Diagnosis | At birth / Newborn screening | At birth (females) / Early childhood (males) | Childhood / Adulthood |
- Salt-Wasting (SW) CAH: The most severe form, where there is little to no enzyme activity. These patients cannot retain salt, which can lead to life-threatening emergencies early in life [5][6].
- Simple Virilizing (SV) CAH: This is the middle of the spectrum. The body retains enough enzyme activity (typically 1–2%) to produce just enough aldosterone to prevent a “salt-wasting crisis,” but it still cannot make enough cortisol [1][3].
- Non-Classic (NC) CAH: The mildest form, often diagnosed later in childhood or adulthood, usually presenting with symptoms related to excess hormones like acne or early puberty [7][1].
Why “Simple Virilizing”?
The term virilization refers to the development of male-typical physical characteristics. Because the “pathway” to make cortisol is blocked, the adrenal glands overproduce other hormones called androgens (male-type sex hormones like testosterone) [2][8].
- In Female Newborns: High levels of androgens before birth can cause the external genitalia to look different (atypical or ambiguous), which often leads to an early diagnosis [8][9].
- In Male Newborns: Because boys already have male-typical genitalia, SV-CAH may not be noticed at birth. Without newborn screening, these boys might be diagnosed later when they show signs of early puberty (such as pubic hair or rapid growth) [10][11].
Diagnosis and Monitoring
Most cases are now caught through newborn screening, which checks levels of a hormone called 17-hydroxyprogesterone (17-OHP) [11][12]. Doctors also use genetic testing (mutational analysis) to confirm the diagnosis and help predict the clinical form [13][14].
Management involves glucocorticoid replacement therapy to replace the missing cortisol [15]. Because the goal is to balance hormone levels, doctors carefully monitor:
- Growth Velocity: Ensuring the child is growing at a healthy rate [16].
- Bone Age: Using X-rays to ensure the bones aren’t maturing too quickly due to androgen excess [16].
- Hormone Levels: Serial blood tests for 17-OHP and androstenedione [17][18].
Life with SV-CAH
With consistent treatment, the prognosis for individuals with SV-CAH is generally excellent [10]. While patients must take medication daily and follow “sick day rules”—increasing the dose during illness to prevent an adrenal crisis—they can lead full, active lives [19][20].
Adults may face specific challenges, such as monitoring for Testicular Adrenal Rest Tumors (TARTs) in men or managing fertility in women, but specialized endocrine care can address these concerns [21][22]. Early diagnosis through screening has significantly improved the long-term health and growth outcomes for children born with this condition [10][11].
Common questions in this guide
What is simple virilizing CAH?
How is simple virilizing CAH diagnosed?
What are the sick day rules for CAH?
How does SV-CAH affect growth and development?
Why do men with SV-CAH need scrotal ultrasounds?
Related questions
Get notified when new evidence is published on Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, simple virilizing form.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (22)
- 1
Genetic characterization of a large cohort of Argentine 21-hydroxylase Deficiency.
Fernández CS, Taboas M, Bruque CD, et al.
Clinical endocrinology 2020; (93(1)):19-27 doi:10.1111/cen.14190.
PMID: 32289882 - 2
The spectrum of CYP21A2 gene mutations in patients with classic salt wasting form of 2l-hydroxylase deficiency in a Chinese cohort.
Liu Y, Zheng J, Liu N, et al.
Molecular genetics & genomic medicine 2020; (8(11)):e1501 doi:10.1002/mgg3.1501.
PMID: 32959514 - 3
Clinical Role of CYP2C19 Polymorphisms in Patients with Congenital Adrenal Hyperplasia Due to 21-hydroxylase Deficiency.
Grošelj U, Žerjav Tanšek M, Trebušak Podkrajšek K, et al.
Acta chimica Slovenica 2016; (63(1)):33-7 doi:10.17344/acsi.2015.1797.
PMID: 26970786 - 4
Genetic Characterization of a Cohort of Italian Patients with Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency.
Concolino P, Perrucci A, Carrozza C, Urbani A
Molecular diagnosis & therapy 2023; (27(5)):621-630 doi:10.1007/s40291-023-00666-x.
PMID: 37548905 - 5
Detection of a novel severe mutation affecting the CYP21A2 gene in a Chilean male with salt wasting congenital adrenal hyperplasia.
Arteaga E, Valenzuela F, Lagos CF, et al.
Endocrine 2020; (67(1)):258-263 doi:10.1007/s12020-019-02097-3.
PMID: 31571129 - 6
Molecular Analysis of 21-Hydroxylase Deficiency Reveals Two Novel Severe Genotypes in Affected Newborns.
Concolino P, Paragliola RM
Molecular diagnosis & therapy 2021; (25(3)):327-337 doi:10.1007/s40291-021-00520-y.
PMID: 33710594 - 7
Non-classical congenital adrenal hyperplasia: current insights into clinical implications, diagnosis and treatment.
Loli P, Menotti S, di Filippo L, Giustina A
Endocrine 2025; (90(1)):1-16 doi:10.1007/s12020-025-04341-5.
PMID: 40699527 - 8
Antenatal Diagnosis and Treatment in Congenital Adrenal Hyperplasia Due to 21-hydroxylase Deficiency and Congenital Adrenal Hyperplasia Screening in Newborns
Yavaş Abalı Z, Kurnaz E, Güran T
Journal of clinical research in pediatric endocrinology 2025; (17(Suppl 1)):33-43 doi:10.4274/jcrpe.galenos.2024.2024-6-10-S.
PMID: 39713885 - 9
How the Child's Gender Matters for Families Having a Child With Congenital Adrenal Hyperplasia.
Fleming L, Knafl K, Van Riper M
Journal of family nursing 2017; (23(4)):516-533 doi:10.1177/1074840717735499.
PMID: 29046104 - 10
Impact of Newborn Screening on Adult Height in Patients With Congenital Adrenal Hyperplasia (CAH).
Hoyer-Kuhn H, Eckert AJ, Binder G, et al.
The Journal of clinical endocrinology and metabolism 2023; (108(11)):e1199-e1204 doi:10.1210/clinem/dgad307.
PMID: 37256841 - 11
Evaluation of the Dutch neonatal screening for congenital adrenal hyperplasia.
van der Linde AAA, Schönbeck Y, van der Kamp HJ, et al.
Archives of disease in childhood 2019; (104(7)):653-657 doi:10.1136/archdischild-2018-315972.
PMID: 30712004 - 12
Newborn Screening for CAH-Challenges and Opportunities.
Heather NL, Nordenstrom A
International journal of neonatal screening 2021; (7(1)) doi:10.3390/ijns7010011.
PMID: 33668620 - 13
Issues with the Detection of Large Genomic Rearrangements in Molecular Diagnosis of 21-Hydroxylase Deficiency.
Concolino P
Molecular diagnosis & therapy 2019; (23(5)):563-567 doi:10.1007/s40291-019-00415-z.
PMID: 31317337 - 14
Rare nonclassic type of Congenital adrenal hyperplasia due to 21-hydroxylase deficiency and genotype-phenotypic correlation.
Hou Y, Li Y, Ai J, Tian L
Heliyon 2024; (10(5)):e27042 doi:10.1016/j.heliyon.2024.e27042.
PMID: 38439885 - 15
Mortality in children with classic congenital adrenal hyperplasia and 21-hydroxylase deficiency (CAH) in Germany.
Dörr HG, Wollmann HA, Hauffa BP, et al.
BMC endocrine disorders 2018; (18(1)):37 doi:10.1186/s12902-018-0263-1.
PMID: 29884168 - 16
The utility of annual growth velocity standard deviation scores and measurements of biochemical parameters in long-term treatment monitoring of children with 21-hydroxylase deficiency.
Ozdemir Dilek S, Turan I, Gurbuz F, et al.
Hormones (Athens, Greece) 2022; (21(3)):391-397 doi:10.1007/s42000-022-00354-1.
PMID: 35243601 - 17
Salivary 17-Hydroxyprogesterone Levels in Children with Congenital Adrenal Hyperplasia: A Retrospective Longitudinal Study Considering Auxological Parameters.
Dubinski I, Bechtold S, Bidlingmaier M, et al.
Hormone research in paediatrics 2023; (96(3)):259-266 doi:10.1159/000526485.
PMID: 35960318 - 18
A 4-hour Profile of 17-hydroxyprogesterone in Salt-wasting Congenital Adrenal Hyperplasia: Is the Serial Monitoring Strategy Worth the Effort?
Besci Ö, Erbaş İM, Küme T, et al.
Journal of clinical research in pediatric endocrinology 2022; (14(2)):145-152 doi:10.4274/jcrpe.galenos.2021.2021-9-17.
PMID: 34866371 - 19
Treatment and Prevention of Adrenal Crisis and Family Education
Çamtosun E, Sangün Ö
Journal of clinical research in pediatric endocrinology 2025; (17(Suppl 1)):80-92 doi:10.4274/jcrpe.galenos.2024.2024-6-12-S.
PMID: 39713905 - 20
Adrenal insufficiency.
Husebye ES, Pearce SH, Krone NP, Kämpe O
Lancet (London, England) 2021; (397(10274)):613-629 doi:10.1016/S0140-6736(21)00136-7.
PMID: 33484633 - 21
Experience in optimizing fertility outcomes in men with congenital adrenal hyperplasia due to 21 hydroxylase deficiency.
King TF, Lee MC, Williamson EE, Conway GS
Clinical endocrinology 2016; (84(6)):830-6 doi:10.1111/cen.13001.
PMID: 26666213 - 22
The impact of CYP21A2 (P30L/I172N) genotype on female fertility in one family.
Kocova M, Anastasovska V, Bitovska I
European journal of medical research 2019; (24(1)):21 doi:10.1186/s40001-019-0379-4.
PMID: 31217034
This page provides educational information about Simple Virilizing CAH. Always consult your endocrinologist or pediatric specialist regarding hormone replacement and sick day rules.